Jacob Chacko
President and CEO at Oric Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Oric Pharmaceuticals Inc., 3 years.
Oric Pharmaceuticals Inc.
Director · PRESIDENT AND CEO
4D Molecular Therapeutics Inc.
Director
Chief executive roles
Oric Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −40,000 | $16.21 | $648,400 |
| Feb 7, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −26,042 | $12.30 | $320,317 |
| Feb 6, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −13,958 | $12.12 | $169,171 |
| Dec 15, 2023 | Oric Pharmaceuticals Inc. | Option exercise | +38,667 | — | — |
| Dec 15, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −14,539 | $8.58 | $124,745 |
| Jul 11, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −5,156 | $8.01 | $41,300 |
| Jul 10, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −10,508 | $8.01 | $84,169 |
| Jul 5, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −4,336 | $8.01 | $34,731 |
| Jun 26, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −20,000 | $8.03 | $160,600 |
| Apr 21, 2023 | 4D Molecular Therapeutics Inc. | Option exercise | +5,000 | $9.41 | $47,050 |
| Apr 21, 2023 | 4D Molecular Therapeutics Inc. | Open-market sale | −5,000 | $20.05 | $100,250 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.